Literature DB >> 16239523

Partially assembled K99 fimbriae are required for protection.

Miguel A Ascón1, Javier Ochoa-Repáraz, Nancy Walters, David W Pascual.   

Abstract

Antibodies to K99 fimbriae afford protection to F5+ bovine enterotoxigenic Escherichia coli (ETEC). Previous studies show that murine dams immunized with Salmonella vaccine vectors stably expressing K99 fimbriae confer protection to ETEC-challenged neonatal pups. To begin to address adaptation of the K99 scaffold to display heterologous B- and T-cell epitopes, studies were conducted to determine how much of the assembled K99 fimbria is required to maintain protective immunity. Sequential deletions in the K99 gene clusters were made, resulting in diminished localization of the K99 fimbrial subunit in the outer membrane. As placement of the K99 fimbrial subunit became progressively contained within the vaccine vector, diminished immunoglobulin A (IgA) and IgG1 antibody titers, as well as diminished Th2-type cytokine responses, were observed in orally immunized mice. Deletion of fanGH, which greatly reduced the export of the fimbrial subunit to the outer membrane, showed only partial reduction in protective immunity. By contrast, deletion of fanDEFGH, which also reduced the export of the fimbrial subunit to the outer membrane but retained more subunit in the cytoplasm, resulted in protective immunity being dramatically reduced. Thus, these studies showed that retention of K99 fimbrial subunit as native fimbriae or with the deletion of fanGH is sufficient to confer protection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239523      PMCID: PMC1273889          DOI: 10.1128/IAI.73.11.7274-7280.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Regulation of host immune responses by modification of Salmonella virulence genes.

Authors:  J L VanCott; S N Chatfield; M Roberts; D M Hone; E L Hohmann; D W Pascual; M Yamamoto; H Kiyono; J R McGhee
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

2.  Differential early interactions between Salmonella enterica serovar Typhi and two other pathogenic Salmonella serovars with intestinal epithelial cells.

Authors:  D L Weinstein; B L O'Neill; D M Hone; E S Metcalf
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Transcriptional organization of the Escherichia coli pilus adhesin K99.

Authors:  O J Inoue; J H Lee; R E Isaacson
Journal:  Mol Microbiol       Date:  1993-11       Impact factor: 3.501

4.  Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.

Authors:  D G Evans; D Y Graham; D J Evans
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

Review 5.  Enterotoxigenic Escherichia coli (ETEC) in farm animals.

Authors:  B Nagy; P Z Fekete
Journal:  Vet Res       Date:  1999 Mar-Jun       Impact factor: 3.683

6.  Murine Wnt-1 with an internal c-myc tag recombinantly produced in Escherichia coli can induce intracellular signaling of the canonical Wnt pathway in eukaryotic cells.

Authors:  Beatrix Fahnert; Johanna Veijola; Giulietta Roël; Minna K Kärkkäinen; Antti Railo; Olivier Destrée; Seppo Vainio; Peter Neubauer
Journal:  J Biol Chem       Date:  2004-08-26       Impact factor: 5.157

7.  Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.

Authors:  S J Savarino; E R Hall; S Bassily; F M Brown; F Youssef; T F Wierzba; L Peruski; N A El-Masry; M Safwat; M Rao; H El Mohamady; R Abu-Elyazeed; A Naficy; A M Svennerholm; M Jertborn; Y J Lee; J D Clemens
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

8.  Vaccination of cows with a K99 extract to protect newborn calves against experimental enterotoxic colibacillosis.

Authors:  B Nagy
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

9.  Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

10.  Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.

Authors:  M A Ascón; D M Hone; N Walters; D W Pascual
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more
  6 in total

1.  Capture efficiency of Escherichia coli in fimbriae-mediated immunoimmobilization.

Authors:  Zhiyong Suo; Xinghong Yang; Muhammedin Deliorman; Ling Cao; Recep Avci
Journal:  Langmuir       Date:  2011-12-28       Impact factor: 3.882

Review 2.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

3.  Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells.

Authors:  Irina Kochetkova; Theresa Trunkle; Gayle Callis; David W Pascual
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

4.  IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen.

Authors:  Javier Ochoa-Repáraz; Agnieszka Rynda; Miguel A Ascón; Xinghong Yang; Irina Kochetkova; Carol Riccardi; Gayle Callis; Theresa Trunkle; David W Pascual
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

5.  Progress in Brucella vaccine development.

Authors:  Xinghong Yang; Jerod A Skyberg; Ling Cao; Beata Clapp; Theresa Thornburg; David W Pascual
Journal:  Front Biol (Beijing)       Date:  2013-02-01

Review 6.  Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens.

Authors:  Moloko Gloria Mathipa; Mapitsi Silvester Thantsha
Journal:  Gut Pathog       Date:  2017-05-08       Impact factor: 4.181

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.